0001415889-21-005011.txt : 20211028
0001415889-21-005011.hdr.sgml : 20211028
20211028200346
ACCESSION NUMBER: 0001415889-21-005011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211026
FILED AS OF DATE: 20211028
DATE AS OF CHANGE: 20211028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bazemore Todd
CENTRAL INDEX KEY: 0001605767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 211360079
MAIL ADDRESS:
STREET 1: C/O DYAX CORP.
STREET 2: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4-10282021_051035.xml
X0306
4
2021-10-26
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001605767
Bazemore Todd
C/O KALA PHARMACEUTICALS, INC.
490 ARSENAL WAY, SUITE 120
WATERTOWN
MA
02472
false
true
false
false
CHIEF OPERATING OFFICER
Common Stock
2021-10-26
4
S
0
12544
1.80
D
122045
D
Common Stock
42
I
By son
This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's performance-based restricted stock units ("RSUs") granted on June 25, 2020.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.89, inclusive. The Reporting Person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Includes 77,500 unvested RSUs.
/s/ Eric Trachtenberg, Attorney-in-Fact
2021-10-28